Mar 31, 2016

GlaxoSmithKline to 'drop patents in poor countries for better drug access'

Chief executive Sir Andrew Witty said he wanted to take a "graduated" approach to the company's "intellectual property" based on the wealth of nations around the globe.

GlaxoSmithKline to 'drop patents in poor countries for better drug access' - BBC News
UK pharmaceutical giant GlaxoSmithKline says it wants to make it easier for manufacturers in the world's poorest countries to copy its medicines so more people can have access to them.